Mark your calendar for Heart Valve Disease Awareness Day on February 22! Join advocates worldwide to raise awareness, detect risks, and improve treatment access. It’s easier than ever to amplify our efforts by sharing resources, events, and facts using our brand new website and social media toolkit. Be sure to use #ValveDiseaseDay to join the discussion on social media.
This year marks a major milestone: 10 years of raising awareness for heart valve disease. Save the date — February 25 — for a special reception on Capitol Hill that will recognize
a decade of awareness.
The Accelerate Cures/Treatments for All neuroDegenerative Diseases (ACT-AD) 18th annual meeting was held January 21. The day-long meeting explored the current therapeutic and research landscape for Alzheimer’s disease and related neurodegenerative conditions.
The Alliance convened experts from academia; biomedical companies; the FDA and the National Institutes of Health (NIH); as well as members of the Alzheimer’s disease community.
Podcast: Looking Beyond the Label
with U.S. Pharmacopeia
Not all supplements are created equal.
From multivitamins to protein powders, supplements crowd store shelves. But how do we know which ones to choose?
Learn why trust in safe, quality medicine matters from an expert at US Pharmacopeia (USP), an independent organization protecting patient safety and improving the health of people around the world.
The Alliancesubmitted public comments applauding the Centers for Medicare & Medicaid Services (CMS) for reconsidering the Transcatheter Aortic Valve Replacement (TAVR) National
Coverage Determination.
The Alliance urges CMS to remove coverage with evidence development – known as CED — and other outdated coverage requirements, and expand national coverage to all FDA-approved uses for the treatment of symptomatic and asymptomatic aortic stenosis.
Comments were shared along with this white paper exploring patient-centered recommendations to increase access to nonprescription drugs and modernize the Rx to OTC switch process.
The Alliance stands ready to be a resource to the FDA as it evaluates strategies to increase nonprescription drug access to
keep America healthy.
In 1986, the Alliance for Aging Research was founded by Daniel Perry with a clear and ambitious purpose: accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health.
This year, we proudly celebrate 40 years of advancing that mission. As we mark this milestone anniversary, we do so with deep gratitude and renewed purpose. Thank you to everyone who has been part of our first 40 years.
